AI and Software Patentability in India in 2026: Section 3(k), the CRI Guidelines, and the Path to Grant

A well-drafted AI or software patent application still has a realistic path to grant in India in 2026, but only when the claims are framed as a technical contribution rather than as a bare algorithm. Section 3(k) of the Patents Act, 1970 is applied strictly. Indian examiners read every claim against the Controller's 2017 Guidelines for Examination of Computer Related Inventions (CRI Guidelines). Founders who treat Form 1 drafting as a coding exercise lose years of prosecution and burn money. Founders who treat it as statutory argumentation get grants.

This post is written for the SaaS founder, AI/ML startup CTO, and DPIIT-recognised technology company that is weighing whether to pursue Indian patent protection for a software or AI invention in 2026. It walks through the statutory framework, how the examination reality works, the forms and fees you will encounter, the rebate structures you can lawfully claim, and three realistic scenarios (India-direct, PCT national-phase, and expedited) with their cost-versus-time trade-offs.

The Patent Landscape for AI and Software in India in 2026

The Indian Patent Office is granting software and AI patents in 2026, but at a fraction of the application rate of mechanical or pharmaceutical inventions, and almost entirely to claims drafted as "technical contribution" rather than "computer programme per se". This is the single most important fact a founder needs to internalise before filing. A claim that recites "a method comprising steps A, B, C implemented in code" will be refused under Section 3(k). A claim that recites "a system comprising a processor configured to perform A in response to B, the processor resolving the technical problem X" has a fighting chance.

Three forces are converging in 2026. First, Section 3(k) of the Patents Act, 1970 has stood unchanged since the Patents (Amendment) Act, 2002, and bars patents on "a mathematical or business method or a computer programme per se or algorithms". Second, the Controller General of Patents, Designs and Trade Marks issued the Guidelines for Examination of Computer Related Inventions (CRI Guidelines) in 2017, and that 2017 document remains the operational reference used by examiners today; there is no CRI Guidelines 2025 or CRI Guidelines 2026, and published cost guides or competitor blog posts that invent those years are wrong on the citation. Third, the Patents (Amendment) Rules, 2024 notified on 15 March 2024 tightened the routine examination-request deadline to 31 months from the priority date for applications filed on or after 15 March 2024, sharpened the renewal ladder, and tightened the Form 27 triennial working-statement structure. The expedited track itself (Form 18A) is older; it predates the 2024 Rules.

The net effect is that an Indian AI or SaaS founder in 2026 has a more disciplined, more transparent prosecution timetable than at any time in the last decade, but the path is still gated by claim-drafting discipline and the willingness to fund a registered patent agent who can argue CRI survival end-to-end.

Section 3(k): What the Statute Actually Bars

Section 3(k) bars patent claims on a "computer programme per se"; it does not bar all software claims. Indian examination practice builds a layered test: is the claim directed solely to a mathematical method, business method, computer programme, or algorithm, or does it recite hardware, a novel technical effect, or a technical application that produces a "technical contribution" as opposed to a purely abstract result? The CRI Guidelines 2017 walk examiners through this test on a claim-by-claim basis.

The practical drafting implication is that claims should not be written as "a method for X implemented in software". They should be written as "a system comprising a processor and a memory storing instructions that cause the processor to perform X, wherein X has the technical effect of Y on Z". Dependent claims should layer in the algorithm detail (the inventive core) to draw examiner attention to the technical contribution while keeping the independent claim technically rooted.

The single most common drafting error is to place the technical contribution (a reduced GPU memory footprint, novel compression of an ML model, real-time inference latency drop) into a dependent claim and leave the independent claim as a bare algorithm. Indian examiners treat the independent claim as the request, and a thin independent claim is refused under Section 3(k) regardless of how strong the dependent claims read.

How the CRI Guidelines 2017 Operate in Practice, Read with Delhi High Court Precedent

The CRI Guidelines 2017 are administrative guidance, not statute, but they bind examiner behaviour the way binding case law binds a tribunal. Section 3(k) sets the rule; the CRI Guidelines tell the examiner how to apply it. A founder who reads the Guidelines carefully learns that "novel hardware", "technical effect on a physical process", and "improvement in the functioning of a computer system itself" are the three levers most likely to satisfy the Guidelines.

The Delhi High Court has read Section 3(k) consistently with the CRI Guidelines. In Ferid Allani v. Union of India (2014, Delhi HC) the Court addressed a method for seamless data transfer between dissimilar storage media and held that the test for Section 3(k) compliance is whether the claimed invention demonstrates a "technical contribution" or a "technical effect" beyond the routine interaction of a general-purpose computer with software. The Court confirmed that formulations reciting a specific hardware configuration interlaced with the algorithm are more likely to overcome Section 3(k) than formulations reciting the algorithm alone. This reading has shaped the Indian Patent Office's subsequent examination practice and is the doctrinal anchor most frequently cited by patent agents when responding to a Section 3(k) first examination report. The contemporary Court-driven reading of "computer programme per se" therefore treats the phrase narrowly; a claim that produces a measurable improvement in the operation of a hardware system, or in a technical field outside the computer itself, is not on the wrong side of Section 3(k) merely because software is involved.

A founder who does not engage with either the Guidelines or this line of precedent is at the mercy of an examiner's first-impression reading. A first-examination-report refusal that says "Claim 1 recites steps performed by a general-purpose computer using a generic algorithm; no technical contribution over the prior art is identified" is the most common Section 3(k) refusal in 2026 and the one that wastes the most client money. The proper response is a Section 57(1) read with Rule 55(1) reply to the FER, recasting the independent claim with hardware-rooted language and clarifying the technical effect. Routine claim amendments in response to a FER are part of standard examination proceedings under Section 57(1) read with Rule 55(1) of the Patents Rules, 2003; they are not a separate, voluntary Form 13 filing. Form 13 under Section 57 read with Rule 81 is the route for substantive voluntary amendments outside a FER response (such as amendments to the complete specification on the Controller's initiative or after grant) and is a distinct procedural instrument.

That first-FER response is itself a substantive cost item, because it is a patent-agent-led argumentation exercise, not a form-filling exercise, and it is the underrated driver of total patent cost in the software vertical. Founders who treat the first office action as the end of the line burn money; founders who budget for a first-response cycle survive Section 3(k).

Forms, Fees, and Timing under the Patents (Amendment) Rules 2024

The most consequential timing change in the 2024 Rules is the routine examination-request deadline reducing from 48 months to 31 months from the priority date, applied to applications filed on or after 15 March 2024. The relevant form is Form 18, filed under Section 11B of the Patents Act, 1970 read with Rule 24B of the Patents Rules, 2003 as substituted by the 2024 Rules. A founder who misses the 31-month deadline loses the application to deemed abandonment under Section 11B(4), and there is no restoration route comparable to the US reinstatement window or the PCT grace-period route. Build a 25 to 28 month internal calendar trigger rather than a 30-month one.

The 2024 Rules did not introduce Form 18A (Expedited Examination). Form 18A was introduced under the Patents (Amendment) Rules, 2016 and refined in the 2019 cycle; it has been available for several years prior to 2024. What the 2024 Rules did was adjust the surrounding examination timetable: the routine Form 18 deadline compressed to 31 months; the annual Rule 80 renewal ladder was restructured; and the Form 27 triennial statement was tightened as to timing and simplified as to content.

Forms that recur on every Indian software patent prosecution:

• Form 1 under Rule 20: the application itself, with abstract, claims, drawings (if any), and complete specification. File multiple claims (independent and dependent), because Section 3(k) refusals are usually answered by claim recursion rather than raw repetition.
• Form 5 under Rule 13(6): the Declaration as to Inventorship, filed at Form 1 submission. Do not confuse Form 5 with amendments; amendments are filed on Form 13 under Section 57 read with Rule 81.
• Form 9 under Rule 24A: the request for early publication. This is a separate form from Form 18. Early publication does not speed up examination; it surfaces the application 18 months earlier, useful in defensive cross-licensing scenarios, sometimes harmful if early competitor visibility is a concern.
• Form 18A: the request for expedited examination introduced by the Patents (Amendment) Rules, 2016 and available to DPIIT-recognised startups, academic applicants, and a short published list of other categories. Indicative timeline to first examination report: 6 to 18 months. Indicative timeline to grant: 2 to 3 years. The 2024 Rules did not introduce this track; it has been operative since 2016.
• Form 25 under Section 39 (Foreign Filing Licence): required only in the specific situations defined by Section 39. An Indian resident is required to obtain Form 25 FFL before filing a corresponding foreign application if (i) the foreign filing will occur before the Indian filing, or (ii) the foreign filing will occur before the expiry of the statutory window (six months under the standard Section 39 route) measured from the Indian filing date, where the Controller has not imposed a secrecy order directing otherwise. If six months have elapsed from the Indian filing date and no secrecy order has been imposed, the Indian applicant may file abroad without a separate Form 25 endorsement. This is a more limited scope than a blanket "before any PCT or US filing" rule, and published guides that overstate the requirement are wrong on the citation.
• Form 27: the post-grant statement on commercial working. Under the 2024 Rules, Form 27 is filed once every three financial years rather than annually and has been significantly simplified, with the requirement to declare specific commercial turnover or revenue values removed. Correctly framed today, Form 27 is a binary working/non-working attestation with a streamlined field schema, not the revenue-disclosure instrument it once was.
• Rule 80 renewal fees: paid annually online to IPO after grant, with fee steps ramping sharply after year 7. Form 21 has nothing to do with renewals; Form 21 is the application for termination of a compulsory licence under Section 94 read with Rule 102(1). Published cost guides that label patent renewals "Form 21" are structurally wrong.

The fee tier under the Patents Rules First Schedule depends on applicant category: natural person, DPIIT-recognised startup, small entity under Rule 2(fb), and "others"/large entity. The Form 1 base fee sits in the lower tier, with substantial additional fees for each excess specification page and each excess claim above ten. Verify any fee figure against the current First Schedule at ipindiaservices.gov.in before quoting.

The Rebate Layer: 80% Fee Reduction for Educational Institutions and DPIIT Startups

The statutory 80% official-fee reduction is available under Rule 6 of the Patents Rules, 2003 as substituted by the Patents (Amendment) Rules, 2016, to two distinct classes of filer: institutions established by a Central, State, or Provincial Act, and DPIIT-recognised startups. For both classes, "80% fee reduction" means these filers pay, in effect, 20% of the standard large-entity official fee across the full prosecution suite (Form 1, Form 5, Form 9, Form 13, Form 18, Form 18A, Form 25, Form 27, Rule 80 renewals). Cumulative savings on a five-year prosecution matter for an eligible filer routinely exceed ₹50,000.

Small entities under Rule 2(fb) and natural persons filing on their own behalf sit on a separate, lower reduced tier, smaller than what educational institutions and DPIIT startups receive, but still meaningfully below the large-entity rate. That tier should likewise be claimed by filing status under Form 1 rather than default-walked past.

The rebate is statutory, not discretionary. A DPIIT-recognised founder should refuse to pay the standard fee tier quietly and ensure that the entity classification recorded on Form 1 (and re-confirmed on every subsequent fee-bearing form) is correctly marked. The 80% reduction is not a flat "across the board" number for every filer category, but for the two classes named in Rule 6 (as substituted), it is the published statutory number.

Cost guides that import a generic "80% across all Indian IP regimes" or quote a flat patent-fee figure across patents, designs, and trademarks are wrong. The Patents Rules fee tiers, the Designs Rules fee tiers, and the Trade Marks Rules Schedule I vs Schedule II fee tiers are structured differently, because trademarks do not use a percentage rebate at all.

Three Realistic Scenarios for an Indian SaaS or AI Founder

Scenario A: India-direct, no PCT

A solo founder files Form 1 in India on a novel AI inference optimisation that demonstrably reduces GPU memory consumption. Skilled in the art is the founder. Patent agent drafts claims at approximately ₹25,000 to ₹60,000; Form 1 plus Form 5 plus Form 9 are filed within one working week, and the priority date clock starts. The founder requests examination on Form 18 at month 25 to leave a six-month buffer ahead of the 31-month Rule 24B deadline. First examination report arrives at month 31 to 34 with a Section 3(k) refusal; the Section 57(1) read with Rule 55(1) FER response costs approximately ₹30,000 to ₹70,000; a second FER follows; grant typically arrives in year 4 to 5. Total professional-services cost is approximately ₹1.5 to ₹3.5 lakh, excluding annual Rule 80 renewals.

Scenario B: PCT international, then India national-phase

A funded startup with a working AI prototype and a US filing priority files PCT within 12 months and enters India national-phase by month 31 under PCT Article 22 (or 32). The Indian national-phase is where Section 3(k) bites hardest, because PCT international examination does not substitute for Indian examination. Form 1, Form 5, Form 18, and a fresh specification adapted to India are required. Working with the same patent agent who prosecuted the PCT international phase is strongly advised, because switching agents at national-phase costs both calendar time and argumentative coherence. Total professional-services cost through grant is approximately ₹4 to ₹8 lakh.

Scenario C: DPIIT-recognised startup using expedited Form 18A

A DPIIT-recognised startup files Form 1, claims the 80% fee reduction under Rule 6, requests Form 18A expedited examination on the startup basis, and pays approximately 20% of the official fees for the full prosecution suite. Indicative timeline to grant is 18 to 30 months, against the 4 to 5 year Scenario A baseline. Total professional-services cost is broadly comparable to Scenario A; the time-to-grant delta is the strategic advantage that justifies the expedited fee burden.

Hidden Costs and Strategic Trade-offs a Founder Should Budget

The hidden cost in Indian software patenting is not the government fee; it is the agent-led response to a Section 3(k) office action. A first examination report refusal under Section 3(k) is the modal outcome for uncarefully drafted claims. The Section 57(1) read with Rule 55(1) FER response is a substantive drafting exercise, not a clerical update, and it often costs as much as the original Form 1 drafting.

Three cost items founders routinely underestimate:

1. Form 25 Foreign Filing Licence: under Section 39, only where required (filing abroad before the Indian filing, or before the statutory window has elapsed without a secrecy order).
2. Form 27 Triennial Statement: filed every three financial years after grant under the 2024 Rules simplified format.
3. Rule 80 Annual Renewal Ladder: steps up sharply after year 7 and through the patent's twenty-year term.

The strategic trade-off worth weighing before the first Form 1 is whether to pursue Section 3(k) survival in India at all, or to bypass India for the first examination cycle via PCT national-phase entry in jurisdictions with friendlier software-patent regimes (EPO, USPTO) and use the resulting granted foreign patent to support a parallel Indian grant via the PCT national-phase track with a more disciplined independent-claim draft. For a Tier-1 SaaS founder with sufficient budget, this dual-track pattern is more reliable than India-first prosecution, and many Tier-2 founders following it avoid a first-cycle Section 3(k) refusal outright.

Frequently Asked Questions About AI and Software Patentability in India in 2026

Can a pure software invention be patented in India in 2026?

Not under Section 3(k) of the Patents Act, 1970, which bars patents on "a computer programme per se". A claim drafted as a technical contribution (a system comprising a processor configured to perform X producing a technical effect Y) has a realistic path to grant. A claim drafted as bare algorithm does not.

Is the CRI Guidelines 2017 still authoritative in 2026?

Yes. The Controller has not replaced the 2017 Guidelines. The operative reading is the CRI Guidelines 2017 read with Section 3(k) of the Patents Act, 1970 and the Delhi High Court's Ferid Allani v. Union of India (2014) line of reasoning on "technical contribution" and "technical effect". There is no CRI Guidelines 2025 or 2026; published posts that cite those fabricated years are wrong on the citation.

What is the routine examination-request deadline after the 2024 Rules?

For applications filed on or after 15 March 2024, the routine examination request under Section 11B read with Rule 24B closes at 31 months from the priority date, filed on Form 18. The 48-month window no longer applies to those applications.

Was Form 18A (Expedited Examination) introduced by the 2024 Rules?

No. Form 18A was introduced by the Patents (Amendment) Rules, 2016 and refined in the 2019 amendment cycle. It has been available since 2016 to DPIIT-recognised startups, academic applicants, and a short published list of other categories. What the 2024 Rules did was adjust the surrounding examination timetable: the routine Form 18 deadline compressed to 31 months, the annual Rule 80 renewal ladder was restructured, and the Form 27 triennial statement was tightened as to timing and simplified as to content.

Does India grant a grace period for prior public disclosure of a software invention?

No general grace period applies. Section 3(k) operates as a strict novelty bar, not as a grace-period exception. Public disclosure before filing (open-source repository release, conference presentation, conference paper, product launch) destroys patentability unless the disclosure falls within the narrow Section 29 grace window, which does not cover routine software publication. The Indian application must file before disclosure.

Can I amend my claims during a First Examination Report response?

Yes. Routine claim amendments in response to a FER are part of standard examination proceedings under Section 57(1) of the Patents Act, 1970 read with Rule 55(1) of the Patents Rules, 2003, and can be made within the FER response itself. Form 13 under Section 57 read with Rule 81 is a separate, substantive instrument reserved for voluntary amendments on the Controller's initiative or amendments made outside a FER response cycle, and is not the default mechanism for routine FER rebuttal.

Does the 80% fee reduction apply to DPIIT startups and educational institutions?

Yes. The 80% official-fee reduction is available under Rule 6 of the Patents Rules, 2003, as substituted by the Patents (Amendment) Rules, 2016, to institutions established by a Central, State, or Provincial Act and to DPIIT-recognised startups. For these filers, "80% reduction" means the filer pays approximately 20% of the standard large-entity fee across the prosecution suite. Small entities under Rule 2(fb) and natural persons filing on their own behalf sit on a separate, lower reduced tier, smaller than the 80%/20% named filer tier, but still meaningfully below the large-entity rate.

What is the Form 25 Foreign Filing Licence requirement?

Under Section 39 of the Patents Act, 1970, an Indian applicant must obtain Form 25 FFL in two specific situations: (i) when the corresponding foreign application will be filed before the Indian application, or (ii) when the corresponding foreign application will be filed within the statutory window (six months under the standard Section 39 route) from the Indian filing date, where the Controller has not imposed a secrecy order directing otherwise. Once six months have elapsed from the Indian filing date without a secrecy order, the Indian applicant may file abroad without a separate Form 25 endorsement.

What changed with Form 27 under the 2024 Rules?

Under the 2024 Rules, Form 27 is filed once every three financial years rather than annually, and the form has been significantly simplified, with the requirement to declare specific commercial turnover or revenue values removed. Today, Form 27 is correctly framed as a binary working/non-working attestation with a streamlined field schema, not as a revenue-disclosure instrument.

How does India handle AI-as-inventor?

India has not formally answered the Thaler/DABUS question by binding precedent at the Controller level. The Patel v Controller General line of decisions has indicated that an AI system is not a "person" under Section 2(1)(t) of the Patents Act. Practical implication: AI cannot be named as inventor; a natural-person inventor must be identified, and inventorship declarations on Form 5 must accurately reflect the human contribution.

Key Terms Explained

• Form 18: the request for examination of a patent application under Section 11B of the Patents Act, 1970 read with Rule 24B of the Patents Rules, 2003. The 31-month deadline under the 2024 Rules applies to this form for applications filed on or after 15 March 2024. Missing the deadline triggers deemed abandonment under Section 11B(4).
• Form 18A: the request for expedited examination introduced by the Patents (Amendment) Rules, 2016 and refined in the 2019 amendment cycle, available to DPIIT-recognised startups, academic applicants, and a short published list of other categories. Indicative timeline to first examination report: 6 to 18 months. Indicative timeline to grant: 2 to 3 years.
• CRI Guidelines 2017: the Controller General of Patents, Designs and Trade Marks' Guidelines for Examination of Computer Related Inventions, operational since 2017, governing how examiners apply Section 3(k). Read with the Delhi High Court's Ferid Allani v. Union of India (2014) line of reasoning on "technical contribution" and "technical effect".
• Section 3(k): the Patents Act, 1970 provision barring patents on "a mathematical or business method or a computer programme per se or algorithms", carved out from patent-eligibility unless framed as a technical contribution.
• Rule 80 renewal fee: the annual online patent renewal fee paid to IPO after grant; the fee steps up sharply after year 7 through the patent's twenty-year term.
• Form 21 (do not confuse with renewals): the application for termination of a compulsory licence under Section 94 read with Rule 102(1) of the Patents Rules, 2003. Patent renewals are paid under Rule 80 online, not on Form 21.
• Form 27: the post-grant statement on commercial working filed once every three financial years under the 2024 Rules simplified format, with no specific commercial turnover or revenue declaration required.